Citadel Advisors’s Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.9K | Sell |
73,545
-6
| -0% | -$2 | ﹤0.01% | 5640 |
|
|
2025
Q1 | $23.5K | Sell |
73,551
-408
| -0.6% | -$131 | ﹤0.01% | 5555 |
|
|
2024
Q4 | $17K | Sell |
73,959
-1,750
| -2% | -$403 | ﹤0.01% | 5664 |
|
|
2024
Q3 | $7.41K | Sell |
75,709
-3,737
| -5% | -$366 | ﹤0.01% | 5483 |
|
|
2024
Q2 | $12.7K | Sell |
79,446
-11,648
| -13% | -$1.86K | ﹤0.01% | 5481 |
|
|
2024
Q1 | $27.6K | Buy |
91,094
+17,349
| +24% | +$5.25K | ﹤0.01% | 5479 |
|
|
2023
Q4 | $4.43K | Buy |
73,745
+432
| +0.6% | +$26 | ﹤0.01% | 5621 |
|
|
2023
Q3 | $7.33K | Sell |
73,313
-45
| -0.1% | -$4 | ﹤0.01% | 5481 |
|
|
2023
Q2 | $12.1K | Sell |
73,358
-1,700
| -2% | -$281 | ﹤0.01% | 5344 |
|
|
2023
Q1 | $9.01K | Buy |
75,058
+1,336
| +2% | +$160 | ﹤0.01% | 5535 |
|
|
2022
Q4 | $10.7K | Buy |
73,722
+296
| +0.4% | +$43 | ﹤0.01% | 5678 |
|
|
2022
Q3 | $15K | Sell |
73,426
-289
| -0.4% | -$59 | ﹤0.01% | 5581 |
|
|
2022
Q2 | $21K | Buy |
73,715
+109
| +0.1% | +$31 | ﹤0.01% | 5705 |
|
|
2022
Q1 | $59K | Buy |
73,606
+187
| +0.3% | +$150 | ﹤0.01% | 5855 |
|
|
2021
Q4 | $139K | Sell |
73,419
-85
| -0.1% | -$161 | ﹤0.01% | 5718 |
|
|
2021
Q3 | $188K | Sell |
73,504
-209
| -0.3% | -$535 | ﹤0.01% | 5467 |
|
|
2021
Q2 | $192K | Hold |
73,713
| – | – | ﹤0.01% | 5604 |
|
|
2021
Q1 | $197K | Buy |
+73,713
| New | +$197K | ﹤0.01% | 5428 |
|